Cargando…

Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis

Ablative fractional laser treatment facilitates epidermal drug delivery, which might be an interesting option to increase the topical efficacy of biological drugs in a variety of dermatological diseases. This work aims at investigating safety and tolerability of this new treatment approach in patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauer, Martin, Lackner, Edith, Matzneller, Peter, Al Jalali, Valentin, Pajenda, Sahra, Ling, Vincent, Böhler, Christof, Braun, Werner, Braun, Reinhard, Boesch, Maximilian, Brunner, Patrick M., Zeitlinger, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322842/
https://www.ncbi.nlm.nih.gov/pubmed/34336906
http://dx.doi.org/10.3389/fmed.2021.712511
_version_ 1783731141558140928
author Bauer, Martin
Lackner, Edith
Matzneller, Peter
Al Jalali, Valentin
Pajenda, Sahra
Ling, Vincent
Böhler, Christof
Braun, Werner
Braun, Reinhard
Boesch, Maximilian
Brunner, Patrick M.
Zeitlinger, Markus
author_facet Bauer, Martin
Lackner, Edith
Matzneller, Peter
Al Jalali, Valentin
Pajenda, Sahra
Ling, Vincent
Böhler, Christof
Braun, Werner
Braun, Reinhard
Boesch, Maximilian
Brunner, Patrick M.
Zeitlinger, Markus
author_sort Bauer, Martin
collection PubMed
description Ablative fractional laser treatment facilitates epidermal drug delivery, which might be an interesting option to increase the topical efficacy of biological drugs in a variety of dermatological diseases. This work aims at investigating safety and tolerability of this new treatment approach in patients with plaque-type psoriasis. Eight patients with plaque-type psoriasis were enrolled in this study. All patients received (i) ablative fractional laser microporation (AFL) of a psoriatic lesion with an Er:YAG laser + etanercept (ETA; Enbrel® solution for injection) (AFL-ETA), (ii) ETA alone on another lesion, and, if feasible, (iii) AFL alone on an additional lesion. Overall, all treatment arms showed a favorable safety profile. AFL-ETA improved the lesion-specific TPSS score by 1.75 vs. baseline, whereas ETA or AFL alone showed a TPSS score improvement of 0.75 points, a difference that was not statistically significant and might be attributable to differences in baseline scores. Topical administration of ETA to psoriatic plaques via AFL-generated micropores was generally well-tolerated. No special precautions seem necessary in future studies. Clinical benefit will need assessment in sufficiently powered follow-up studies.
format Online
Article
Text
id pubmed-8322842
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83228422021-07-31 Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis Bauer, Martin Lackner, Edith Matzneller, Peter Al Jalali, Valentin Pajenda, Sahra Ling, Vincent Böhler, Christof Braun, Werner Braun, Reinhard Boesch, Maximilian Brunner, Patrick M. Zeitlinger, Markus Front Med (Lausanne) Medicine Ablative fractional laser treatment facilitates epidermal drug delivery, which might be an interesting option to increase the topical efficacy of biological drugs in a variety of dermatological diseases. This work aims at investigating safety and tolerability of this new treatment approach in patients with plaque-type psoriasis. Eight patients with plaque-type psoriasis were enrolled in this study. All patients received (i) ablative fractional laser microporation (AFL) of a psoriatic lesion with an Er:YAG laser + etanercept (ETA; Enbrel® solution for injection) (AFL-ETA), (ii) ETA alone on another lesion, and, if feasible, (iii) AFL alone on an additional lesion. Overall, all treatment arms showed a favorable safety profile. AFL-ETA improved the lesion-specific TPSS score by 1.75 vs. baseline, whereas ETA or AFL alone showed a TPSS score improvement of 0.75 points, a difference that was not statistically significant and might be attributable to differences in baseline scores. Topical administration of ETA to psoriatic plaques via AFL-generated micropores was generally well-tolerated. No special precautions seem necessary in future studies. Clinical benefit will need assessment in sufficiently powered follow-up studies. Frontiers Media S.A. 2021-07-16 /pmc/articles/PMC8322842/ /pubmed/34336906 http://dx.doi.org/10.3389/fmed.2021.712511 Text en Copyright © 2021 Bauer, Lackner, Matzneller, Al Jalali, Pajenda, Ling, Böhler, Braun, Braun, Boesch, Brunner and Zeitlinger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Bauer, Martin
Lackner, Edith
Matzneller, Peter
Al Jalali, Valentin
Pajenda, Sahra
Ling, Vincent
Böhler, Christof
Braun, Werner
Braun, Reinhard
Boesch, Maximilian
Brunner, Patrick M.
Zeitlinger, Markus
Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
title Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
title_full Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
title_fullStr Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
title_full_unstemmed Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
title_short Phase I Study to Assess Safety of Laser-Assisted Topical Administration of an Anti-TNF Biologic in Patients With Chronic Plaque-Type Psoriasis
title_sort phase i study to assess safety of laser-assisted topical administration of an anti-tnf biologic in patients with chronic plaque-type psoriasis
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8322842/
https://www.ncbi.nlm.nih.gov/pubmed/34336906
http://dx.doi.org/10.3389/fmed.2021.712511
work_keys_str_mv AT bauermartin phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT lackneredith phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT matznellerpeter phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT aljalalivalentin phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT pajendasahra phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT lingvincent phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT bohlerchristof phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT braunwerner phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT braunreinhard phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT boeschmaximilian phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT brunnerpatrickm phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis
AT zeitlingermarkus phaseistudytoassesssafetyoflaserassistedtopicaladministrationofanantitnfbiologicinpatientswithchronicplaquetypepsoriasis